Trifluridine/tipiracil (FTD/TPI) and regorafenib (REG) in patients with metastatic colorectal cancer (mCRC): A single institution retrospective study-MedSci.cn

Trifluridine/tipiracil (FTD/TPI) and regorafenib (REG) in patients with metastatic colorectal cancer (mCRC): A single institution retrospective study

Patel, AK; Ng, K; Duh, MS; Barghout, VE; Huynh, L; Yenikomshian, MA; Sharperson, C; Brais, LK; Fuchs, CS

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (4):

科室
- - 订阅+
  - 更多科室
工具
服务